JOUNCE THERAPEUTICS, INC.: cashflow_investing

Value{"amount": 43744000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2020-01-01 – 2020-03-31
Statuscurrent
EntityJOUNCE THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001640455-20-000051 · Open the official SEC filing →
Retrieved: 2026-08-19T16:52:41.747109+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001640455/cashflow-investing/2020-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f776b19a-2304-4e94-aaff-65febd330210

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies